KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Other financing activities (2016 - 2025)

Historic Other financing activities for LifeMD (LFMD) over the last 10 years, with Q3 2025 value amounting to $3.2 million.

  • LifeMD's Other financing activities rose 3357.24% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year decrease of 1431.9%. This contributed to the annual value of $12.2 million for FY2024, which is 203.81% down from last year.
  • Latest data reveals that LifeMD reported Other financing activities of $3.2 million as of Q3 2025, which was up 3357.24% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Other financing activities ranged from a high of $4.5 million in Q1 2022 and a low of $1.9 million during Q4 2022
  • Moreover, its 5-year median value for Other financing activities was $3.1 million (2024), whereas its average is $3.0 million.
  • Over the last 5 years, LifeMD's Other financing activities had its largest YoY gain of 232520.86% in 2021, and its largest YoY loss of 8100.49% in 2021.
  • Over the past 5 years, LifeMD's Other financing activities (Quarter) stood at $3.1 million in 2021, then tumbled by 39.42% to $1.9 million in 2022, then skyrocketed by 93.44% to $3.6 million in 2023, then fell by 14.83% to $3.1 million in 2024, then increased by 3.0% to $3.2 million in 2025.
  • Its Other financing activities was $3.2 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.5 million in Q1 2025.